Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Prof. Jan Vijg Albert Einstein College of Medicine, USA2 Talks
Jan Vijg, Ph.D., is Professor and Chairman of the Department of Genetics at the Albert Einstein College of Medicine in New York since 2008. He received his Ph.D. from the University of Leiden, The Netherlands, in 1987, and was previously an Associate Professor of Medicine at Harvard Medical School in... read moreBoston (1993-1999), a Professor of Physiology at the University of Texas Health Science Center in San Antonio, Texas (1999-2005), and a Professor at the Buck Institute for Research on Aging, Novato, California (2006-2008). With his research team he was the first to develop transgenic mouse models for studying mutagenesis in vivo (in 1989) and used these models ever since in studying the possible relationship between damage to the genome and aging. He has published more than 250 scientific articles, is inventor or co-inventor on 8 patents and co-founded two biotechnology companies. He is currently developing single-cell, whole genome sequencing methods to study somatic mutations and epimutations in cancer and aging.